简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-06-12 09:44 Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations
2026-06-11 16:47 Parse Biosciences Launches the Next Generation of its Immune Profiling Kits
2026-06-11 14:33 Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments
2026-06-11 14:16 Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems
2026-06-11 14:09 Roquette Showcases Scalable Drug Delivery Innovations at CPHI China 2026
2026-06-10 17:17 New Polymorph of Indomethacin Discovered
2026-06-10 13:33 Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Support the Company’s Advancement Toward Commercialization
2026-06-10 11:20 New Study Reveals the True Environmental Impact of Periodontal Disease – And What You Can Do About It
2026-06-10 10:39 Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
2026-06-09 11:55 Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1
2026-06-09 11:50 Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy
2026-06-09 11:46 Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy
2026-06-08 11:35 Tsuno Rice Fine Chemicals: Comparative Absorption Study of Rice Bran-Derived “Rice Magnesium” Reveals New Insights into Its Gradual, Sustained Absorption Profile
2026-06-05 10:33 New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa
2026-06-03 12:04 BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
2026-06-01 13:19 BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
2026-06-01 11:06 SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
2026-06-01 11:01 Rubedo’s RLS-1496 Reduces Actinic Keratosis Pre-Cancerous Skin Lesions by 46% at Four Weeks with Minimal Irritation in Preliminary Results of Phase 1b/2a Study
2026-05-29 10:27 BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
2026-05-28 11:37 Parse Biosciences and bit.bio Announce Landmark Alliance

Business Wire Weibo

Press Releases

Latest Releases